EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis

Rasanpreet Kaur iD, Saurabh Gupta iD, Sunanda Kulshrestha iD, Vishal Khandelwal, Swadha Pandey, Anil Kumar iD, Gaurav Sharma iD, Umesh Kumar iD, Deepak Parashar iD, Kaushik Das iD

Cells · 25.12.2024 · 14 (1) · 5

DOI: 10.3390/cells14010005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 25.12.2024. Verfasst von Rasanpreet Kaur und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Institute of Applied Sciences & Humanities, GLA University, Chaumuhan, Mathura 281406, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Breast Neoplasms, Metabolomics, Biomarkers, Tumor. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 226 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Biotechnology, Government of India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Breast cancer is a cancer with global prevalence and a surge in the number of cases with each passing year. With the advancement in science and technology, significant progress has been achieved in the prevention and treatment of breast cancer to make ends meet. The scientific intradisciplinary subject of “metabolomics” examines every metabolite found in a cell, tissue, system, or organism from different sources of samples. In the case of breast cancer, little is known about the regulatory pathways that could be resolved through metabolic reprogramming. Evidence related to the significant changes taking place during the onset and prognosis of breast cancer can be obtained using metabolomics. Innovative metabolomics approaches identify metabolites that lead to the discovery of biomarkers for breast cancer therapy, diagnosis, and early detection. The use of diverse analytical methods and instruments for metabolomics includes Magnetic Resonance Spectroscopy, LC/MS, UPLC/MS, etc., which, along with their high-throughput analysis, give insights into the metabolites and the molecular pathways involved. For instance, metabolome research has led to the discovery of the glutamate-to-glutamate ratio and aerobic glycolysis as biomarkers in breast cancer. The present review comprehends the updates in metabolomic research and its processes that contribute to breast cancer prognosis and metastasis. The metabolome holds a future, and this review is an attempt to amalgamate the present relevant literature that might yield crucial insights for creating innovative therapeutic strategies aimed at addressing metastatic breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMetabolomicsBiomarkers, TumorHumansFemalePrognosisMetabolome

Stichwörter der Autor:innen

biomarkersbreast cancermetabolomicsmetastasistherapeutics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biotechnology, Institute of Applied Sciences & Humanities, GLA University, Chaumuhan, Mathura 281406, Uttar Pradesh, India.
  • Division of Hematology & Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226, USA.
  • National Institute of Immunology, New Delhi 110067, India.
  • Cardiovascular and Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Advanced Imaging Research Center (AIRC), University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

ORCID-Profile: Rasanpreet Kaur, Saurabh Gupta, Sunanda Kulshrestha, Anil Kumar, Gaurav Sharma, Umesh Kumar, Deepak Parashar, Kaushik Das

Förderung

  • Department of Biotechnology, Government of India

Zitieren

APA

Kaur, R., Gupta, S., Kulshrestha, S., Khandelwal, V., Pandey, S., Kumar, A., Sharma, G., Kumar, U., Parashar, D., & Das, K. (2024). Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis. Cells, 14(1), 5. https://doi.org/10.3390/cells14010005

Vancouver

Kaur R, Gupta S, Kulshrestha S, Khandelwal V, Pandey S, Kumar A, et al. Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis. Cells. 2024;14(1):5. doi:10.3390/cells14010005

BibTeX
@article{Kaur2024,
  author = {Kaur, Rasanpreet and Gupta, Saurabh and Kulshrestha, Sunanda and Khandelwal, Vishal and Pandey, Swadha and Kumar, Anil and Sharma, Gaurav and Kumar, Umesh and Parashar, Deepak and Das, Kaushik},
  title = {Metabolomics-Driven Biomarker Discovery for Breast Cancer Prognosis and Diagnosis},
  journal = {Cells},
  year = {2024},
  volume = {14},
  number = {1},
  pages = {5},
  doi = {10.3390/cells14010005}
}
Kostenlos starten →